1 March 2020 in Journal of Neuroscience Methods
11 July 2019 in JBMR Plus
Antiresorptive denosumab is known to improve the quality and strength of cortical bone in the proximal femurs of osteoporotic women, but its efficacy in preventing periprosthetic bone loss and reducing femoral stem migration has not been studied in women undergoing cementless total hip arthroplasty. We conducted a single‐center, randomized, double‐blinded, placebo‐controlled trial of 65 postmenopausal women with primary hip osteoarthritis and Dorr type A or B proximal femur anatomy. The patients randomly received subcutaneous injections of denosumab 60 mg or placebo once every 6 months for 12 months, starting 1 month before surgery. The primary endpoint was the change in bone mineral density (BMD) of the proximal femur (Gruen zone 7) at week 48, and the secondary endpoint was stem subsidence measured by radiostereometric analysis (RSA) at week 48. Exploratory endpoints included changes in BMDs of the contralateral hip, lumbar spine and distal radius, serum levels of bone turnover markers, walking speed, walking activity, patient‐reported outcome measures, and radiographic assessment of stem osseointegration. The participants underwent vertebral‐fracture assessment in an extension safety study at 3 years. Denosumab significantly decreased bone loss in the medial femoral neck (zone 7) and increased periprosthetic BMD in the greater trochanteric region (zone 1) and lesser trochanteric region (zone 6). Denosumab did not reduce temporary femoral stem migration. The migration occurred mainly during the settling period (0 to 12 weeks) after implantation of the prosthesis. All of the stems osseointegrated, as evaluated by RSA and radiographs. There were no intergroup differences in functional recovery. Discontinuation of denosumab did not lead to any adverse events. In conclusion, denosumab increased periprosthetic BMD in the clinically relevant regions of the proximal femur, but the treatment response was not associated with any reduction of initial stem migration. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.
1 April 2025 in Radiology
Deep learning applications have permeated acute ischemic stroke imaging, particularly for stroke lesion segmentation; however, challenges remain, including the need for standardized protocols and test sets, larger public datasets, and performance validation in real-world settings.
21 April 2025 in IEEE Transactions on Radiation and Plasma Medical Sciences
The signal-to-noise ratio (SNR) of positron emission tomography (PET) images is determined by several factors including the geometry of the scanner. Low system sensitivity caused by a short axial field of view (FOV) results in a low reconstructed image SNR that can complicate clinical decision-making. Therefore, a longer FOV is highly desirable (e.g., a total body geometry). However, this raises the scanner’s cost by increasing the volume of crystals, number of detectors, and readout electronics. We have developed a deep-learning framework to enhance the image quality of data acquired from a prototype brain-dedicated PET insert system for PET/MRI with an axial FOV of just 2.8 cm. We employed a retrospective analysis on 18F-fluorodeoxyglucose PET scans of 28 patients with either Glioblastoma (n=9) or Alzheimer’s disease (n=19) acquired on a commercial PET/MRI scanner with 60 cm diameter and 25 cm axial FOV. From this data we reconstructed low statistics PET images mimicking that acquired from the 2.8 cm axial FOV brain PET prototype using the 25 cm axial FOV commercial system dataset using a "fault-tolerant reconstruction" algorithm, which allowed us to constrain the count statistics from a set of detectors in a single ring of the latter system to match the geometry of the former system. A conditional generative adversarial network (cGAN) was trained and tested using the simulated short axial FOV images as input, with the paired 25 cm axial FOV image data as the target. We performed 5-fold cross-validation and compared the deep learning (DL)-enhanced images to the target images using 4 metrics: peak-signal-to-noise-ratio (PSNR), root mean squared error (RMSE), mean absolute error (MAE), and structural similarity index (SSIM). The DL-enhanced PET images from the 2.8 cm axial FOV system had a median PSNR of 39.09 (interquartile range (IQR): 32.80–45.32), a median SSIM of 0.98 (IQR: 0.97–0.99), a median RMSE of 0.07 (IQR: 0.04–0.09), and a median MAE of 0.004 (IQR: 0.000–0.009). We also assessed the pretrained cGAN model’s performance in a zero-shot denoising task using patient data collected with our first generation PETcoil system. The ability of the cGAN model to enhance the quality of PET images acquired with a short axial FOV suggests a potential method to provide high-quality, high-accuracy images comparable to those of large axial FOV systems.